GeneNews, Ltd. is a leader in advanced molecular diagnostics for the early detection of cancer. An innovator in the liquid biopsy space, GeneNews is committed to developing solutions for patients and physicians to find cancer early, when it is most treatable. In addition to building a pipeline of proprietary products, GeneNews is also dedicated to researching, licensing and making commercially available diagnostics that can aid healthcare providers in improving healthcare outcomes through early interventions.

Our Richmond, Virginia-based laboratory, Innovative Diagnostic Laboratory (IDL), is a clinical reference lab that develops and offers advanced, blood based molecular diagnostics (liquid biopsy) for early cancer diagnosis for the U.S.

Recent News
Aug 15, 2018

Closed on the first tranche of the Unit private placement for C$1.2 million and the Lind convertible security for C$2 million Number of enrolled and active practices continues to grow...

Aug 15, 2018

GeneNews Limited (TSX: GEN), an innovator in the liquid biopsy space, today announced a partnership with Pittsburgh-based, LifeX™, a strategic engine for developing and nurturing cutting-edge,...

Aug 13, 2018

In the news release, GeneNews Second Quarter 2018 Operating and Financial Results, issued 10-Aug-2018 by GeneNews Limited over Cision, we are advised by the company that the date of the Conference...

View More


445 Apple Creek Blvd. Unit 220 
Markham, ON, Canada L3R 9X7 

Tel: 905-209-2030 X2024
Fax: 905-209-2031 
Toll Free: 1-866-375-0442